Meetings:

Federal Register Volume 76, Number 138 (Tuesday, July 19, 2011)

Notices

Pages 42714-42715

From the Federal Register Online via the Government Printing Office [www.gpo.gov]

FR Doc No: 2011-18063

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

Docket No. FDA-2011-N-0002

Science Board Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public.

Name of Committee: Science Board to the Food and Drug

Administration (Science Board).

General Function of the Committee: The Science Board provides advice primarily to the Commissioner of Food and Drugs and other appropriate officials on specific complex and technical issues, as well as emerging issues within the scientific community in industry and academia. Additionally, the Science Board provides advice to the Agency on keeping pace with technical and scientific evolutions in the fields of regulatory science, on formulating an appropriate research agenda, and on upgrading its scientific and research facilities to keep pace with these changes. It will also provide the means for critical review of Agency-sponsored intramural and extramural scientific research programs.

Date and Time: The meeting will be held on Friday, August 19, 2011, from 9 a.m. to 3 p.m.

Location: FDA White Oak Campus, 10903 New Hampshire Ave., Building 31 Conference Center, the Great Room (rm. 1503), Silver Spring, MD 20993-0002. For those unable to attend in person, the meeting will also be Web cast. The link for the Web cast is available at https://collaboration.fda.gov/scienceboard/. Information regarding special accommodations due to a disability, visitor parking, and transportation may be accessed at: http://www.fda.gov/AdvisoryCommittees/default.htm; under the heading ``Resources for You,'' click on ``Public Meetings at the FDA White Oak Campus.'' Please note that visitors to the White Oak

Campus must enter through Building 1.

Contact Person: Martha Monser, Office of the Chief Scientist,

Office of the Commissioner, Food and Drug Administration, 10903 New

Hampshire Ave., Bldg. 32, rm. 4286, Silver Spring, MD 20993-0002, 301- 796-4627, or FDA Advisory Committee Information Line, 1-800-741-8138

(301-443-0572 in the Washington, DC area), and follow the prompts to the desired center or product area. Please call the Information Line for up-to-date information on this meeting. A notice in the Federal

Register about last minute modifications that impact a previously announced advisory committee meeting cannot always be published quickly enough to provide timely notice. Therefore, you should always check the

Agency's Web site and call the appropriate advisory committee hot line/ phone line to learn about possible modifications before coming to the meeting.

Agenda: On August 19, 2011, the Science Board will discuss the

FDA's draft Strategic Plan for Regulatory Science. The Board will be provided with an update on the FDA's Medical Countermeasures Initiative program plans. The Board will also initiate the charges to the subcommittees for: (1) A science review of the Center for Devices and

Radiological Health, and (2) a Medical and Biological Engineering review.

FDA intends to make background material available to the public no later than 2 business days before the meeting. If FDA is unable to post the background material on its Web site prior to the meeting, the background material will be made publicly available at the location of the advisory committee meeting, and the background material will be posted on FDA's Web site after the meeting.

Background material is available at http://www.fda.gov/AdvisoryCommittees/Calendar/default.htm. Scroll down to the appropriate advisory committee link.

Procedure: Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee.

Written submissions may be made to the contact person on or before

Friday, August 12, 2011. Oral presentations from the public will be scheduled between approximately 1 and 2 p.m. Those individuals interested in making formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation on or before Thursday, August 4, 2011. Time allotted for each presentation may be limited. If the number of registrants requesting to speak is greater than can be reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested persons regarding their request to speak by Friday, August 5, 2011.

Persons attending FDA's advisory committee meetings are advised that the Agency is not responsible for providing access to electrical outlets.

FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with physical disabilities or special needs. If you require special accommodations due to a disability, please contact Martha Monser, at least 7 days in advance of the meeting.

Page 42715

FDA is committed to the orderly conduct of its advisory committee meetings. Please visit our Web site at http://www.fda.gov/oc/advisory/default.htm for procedures on public conduct during advisory committee meetings.

Notice of this meeting is given under the Federal Advisory

Committee Act (5 U.S.C. app. 2).

Dated: July 12, 2011.

Leslie Kux,

Acting Assistant Commissioner for Policy.

FR Doc. 2011-18063 Filed 7-18-11; 8:45 am

BILLING CODE 4160-01-P